Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

Under new platform, drugs could soon be approved with accompanying software applications that could monitor adverse events or patient compliance without a separate premarket device review.

Data synchronization of health book between smartwatch and smartphone in male hands

The US FDA expects to soon release its digital health tools platform that will allow software applications to be approved in conjunction with new drugs and included in labeling.

Under the plan, these software applications may not require separate approval by the Center for Devices and Radiological Health. Commissioner...

More from Digital Technologies

More from Advanced Technologies

Branch Chief Vijay Kumar Named Acting Head Of US FDA’s Cell, Gene Therapy Office

 

Kumar takes over as acting director of the Center for Biologics Evaluation and Research’s Office of Therapeutic Products days after director Nicole Verdun was ousted.

EMA Nod For First MASH Drug Rezdiffra, Cell Therapy Zemcelpro And 11 Others

 

Madrigal Pharmaceuticals’ Rezdiffra is on track to become the first medicine approved in the EU for non-cirrhotic metabolic dysfunction-associated steatohepatitis after the European Medicines Agency recommended that it be granted conditional marketing authorization.

AI Will Bolster, Not Squelch, Patient Voice In Clinical Research, US FDA Says

 
• By 

Artificial intelligence tools used for clinical research should be developed with input from patients and focus on their needs and abilities, FDA experts said.